Plaisance Capital’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Hold
0
14
2022
Q1
Hold
0
16
2021
Q4
Hold
0
35
2021
Q3
Sell
-15,230
Closed -$2.47M 30
2021
Q2
$2.47M Buy
+15,230
New +$2.47M 1.23% 16